At a glance
ClinicalIndex Comparison RecordN/ACompleted· 112 enrolled
Drug / intervention
Vitamin D3 oral regimendietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Vitamin D Oral Replacement in Asthma
IDeA States Pediatric Clinical Trials Network·interventional·Posted Sep 26, 2018·Updated Apr 19, 2023
In Brief
A clinical study evaluating Vitamin D3 oral regimen for Asthma and 2 related conditions. Completed, enrolled 112 participants across 15 sites.
Detailed Summary
The overall objective of the study is to determine the pharmacokinetics of Vitamin D supplementation in children who have asthma and are overweight or obese.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAsthma, Vitamin D Deficiency, Pediatric Obesity
CountriesUnited States
CollaboratorsNational Institutes of Health (NIH)
Timeline
N/ACompletedFinished
20192020202120222023202420252026
First PostedSep 2018
Enrollment StartJan 2019
Primary CompletionSep 2021
TodayJul 2026
First PostedSep 26, 2018
Enrollment StartJan 30, 2019
Primary CompletionSep 30, 2021
TodayJul 2, 2026
Enrollment to primary: 2.7 yearsPosted 7.8 years ago
Interventions
Vitamin D3 oral regimendietary
Vitamin D3 oral regimens supplementation